Atovaquone and Proguanil Hydrochloride Tablets 250 mg

Atovaquone and Proguanil Hydrochloride Tablets 250 mg are a combination medication used for malaria prevention and treatment. This oral tablet is manufactured by Glenmark Pharmaceuticals Canada Inc.

Atovaquone and Proguanil Hydrochloride Tablets are primarily used for the prevention and treatment of malaria, a mosquito-borne disease. This combination medication is often prescribed for travelers to areas where malaria is common. The tablets work by interfering with the growth of parasites in the red blood cells, helping to manage or prevent malaria infections.

Common effects of Atovaquone and Proguanil Hydrochloride Tablets may include nausea, vomiting, diarrhea, and headache. Some users might experience abdominal pain or loss of appetite. These effects vary among individuals and are not experienced by everyone who takes the medication.

Atovaquone and Proguanil Hydrochloride Tablets should be used with caution in individuals with severe kidney or liver problems. It is important to follow the prescribed dosage and complete the full course of treatment. Always consult a healthcare provider before starting this medication, especially if you have any pre-existing medical conditions or are taking other medications.

Atovaquone and Proguanil Hydrochloride Tablets may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.